{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:33:18Z","timestamp":1762864398015,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":249,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1002\/rth2.12750","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T07:32:55Z","timestamp":1655796775000},"page":"e12750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Thrombotic thrombocytopenia After Sinopharm BBIBP\u2010CorV COVID\u201019 vaccination"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9399-3854","authenticated-orcid":false,"given":"Rezvan","family":"Hosseinzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-9370","authenticated-orcid":false,"given":"Mohammad","family":"Barary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Mehdinezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence T.","family":"Sio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8339-3118","authenticated-orcid":false,"given":"Sahar","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12750_bb0010","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV\u201019 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12750_bb0015","unstructured":"World Health Organization. Bangladesh: WHO coronavirus disease (COVID\u201019) dashboard with vaccination data | WHO coronavirus (COVID\u201019) dashboard with vaccination data. World health Organization 2021: 1\u20135."},{"key":"10.1002\/rth2.12750_bb0020","unstructured":"World Health Organization (WHO). World Health Organisation Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) \u2013 29 April 2021. Available at: Who.2021."},{"key":"10.1002\/rth2.12750_bb0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP\u2010CorV, with potent protection against SARS\u2010CoV\u20102","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1002\/rth2.12750_bb0030","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov\u201019 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12750_bb0035","unstructured":"Schuchat A, Marks P. Joint CDC and FDA statement on Johnson & Johnson COVID\u201019 vaccine: the following statement is attributed to Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research: (U.S.) C for DC and P, (U.S.) C for BE and R, editors. Atlanta, GA; 2021: 1\u20132."},{"key":"10.1002\/rth2.12750_bb0040","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1002\/rth2.12750_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1469-7481","article-title":"Diagnosis and management of vaccine\u2010related thrombosis following AstraZeneca COVID\u201019 vaccination: guidance statement from the GTH","volume":"41","author":"Oldenburg","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1002\/rth2.12750_bb0050","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin\u2010induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12750_bb0055","article-title":"Differences in venous immunothrombosis in severe COVID\u201019 pneumonia and vaccine\u2010induced thrombotic thrombocytopenia (VITT) \u2013 It's in the viral DNA","volume":"121","author":"McGonagle","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1002\/rth2.12750_bb0060","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine\u2010induced prothrombotic immune thrombocytopenia (VIPIT)","volume":"19","author":"Thaler","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12750_bb0065","doi-asserted-by":"crossref","first-page":"2036556","DOI":"10.1080\/21645515.2022.2036556","article-title":"VITT with inactivated SARS\u2010CoV\u20102 vaccine \u2010 index case","volume":"18","author":"Devi","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1002\/rth2.12750_bb0070","series-title":"UpToDate","article-title":"VITT\u2010adapted 4Ts scoring system","author":"Warkentin","year":"2021"},{"key":"10.1002\/rth2.12750_bb0075","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1055\/a-1481-3039","article-title":"Vaccine\u2010induced immune thrombotic thrombocytopenia (VITT): targeting Pathomechanisms with Bruton tyrosine kinase inhibitors","volume":"121","author":"von Hundelshausen","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12750_bb0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ajh.26258","article-title":"Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy","volume":"96","author":"Dhoot","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1002\/rth2.12750_bb0085","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV\u201019 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12750_bb0090","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine\u2010induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12750","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12750","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922012419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922012419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:25:16Z","timestamp":1762863916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922012419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2475037922012419"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12750","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic thrombocytopenia After Sinopharm BBIBP\u2010CorV COVID\u201019 vaccination","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}],"article-number":"e12750"}}